Lilly to participate in J.P. Morgan Healthcare Conference
Eli Lilly and Company (NYSE: LLY) will participate in the 44th Annual J.P.
Rhea-AI Summary
Eli Lilly and Company (NYSE: LLY) will participate in the 44th Annual J.P. Morgan Healthcare Conference, scheduled for Jan. 12-15, 2025. David A. Ricks, Lilly chair and CEO, will appear in a fireside chat on Tuesday, Jan. 13 at 5:15 p.m. ET.
A live audio webcast will be accessible via the company's Webcasts & Presentations investor page and a replay will be available on the same site for approximately 90 days.
Positive
- None.
Negative
- None.
Details
News Market Reaction – LLY
On Dec 16, the day this news came out, LLY closed 0.74% below the previous close.
Data tracked by StockTitan Argus for the Dec 16 session.
Key Figures
- Conference edition
- 44th Annual
- J.P. Morgan Healthcare Conference
- Conference dates
- Jan. 12–15, 2025
- J.P. Morgan Healthcare Conference schedule
- Fireside chat time
- 5:15 p.m. ET
- CEO session on Tuesday, Jan. 13
- Replay availability
- approximately 90 days
- Webcast replay on investor website
Historical Context
-
Updated EMBER-3 data reinforced efficacy and OS trends in advanced breast cancer.
-
TRIUMPH-4 topline showed up to 28.7% weight loss and pain reduction with retatrutide.
-
Announcement of >$6B Alabama API facility and thousands of new jobs through 2032.
-
Completion of Adverum tender offer with cash plus CVR structure ahead of closing.
-
Jaypirca reduced progression or death risk by 80% vs chemoimmunotherapy in CLL/SLL.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
A live audio webcast will be available on the "Webcasts & Presentations" section of Lilly's investor website at https://investor.lilly.com/webcasts-and-presentations. A replay of the presentation will be available on this same website for approximately 90 days.
About Lilly
Lilly is a medicine company turning science into healing to make life better for people around the world. We've been pioneering life-changing discoveries for nearly 150 years, and today our medicines help tens of millions of people across the globe. Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing new discoveries to solve some of the world's most significant health challenges: redefining diabetes care; treating obesity and curtailing its most devastating long-term effects; advancing the fight against Alzheimer's disease; providing solutions to some of the most debilitating immune system disorders; and transforming the most difficult-to-treat cancers into manageable diseases. With each step toward a healthier world, we're motivated by one thing: making life better for millions more people. That includes delivering innovative clinical trials that reflect the diversity of our world and working to ensure our medicines are accessible and affordable. To learn more, visit Lilly.com and Lilly.com/news, or follow us on Facebook, Instagram, and LinkedIn. F-LLY
Trademarks and Trade Names
All trademarks or trade names referred to in this press release are the property of the company, or, to the extent trademarks or trade names belonging to other companies are references in this press release, the property of their respective owners. Solely for convenience, the trademarks and trade names in this press release are referred to without the ® and ™ symbols, but such references should not be construed as any indicator that the company or, to the extent applicable, their respective owners will not assert, to the fullest extent under applicable law, the company's or their rights thereto. We do not intend the use or display of other companies' trademarks and trade names to imply a relationship with, or endorsement or sponsorship of us by, any other companies.
Refer to: | Ashley Hennessey; gentry_ashley_jo@lilly.com; 317-416-4363 (Media) |
Michael Czapar; czapar_michael_c@lilly.com; 317-617-0983 (Investors) |
View original content to download multimedia:https://www.prnewswire.com/news-releases/lilly-to-participate-in-jp-morgan-healthcare-conference-302640506.html
SOURCE Eli Lilly and Company
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.